Company: ZVRA
Filing Date: 2025-03-13
Form Type: S-8
Source: 0001437749-25-007343
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-13
Form: S-8
Chunk 2
---
                                                                                                                                                                                                                                              |
| 23.1*   | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.                                                                                                                                                                                                   |
| 23.3*   | Consent of Latham & Watkins LLP (included in Exhibit 5.1).                                                                                                                                                                                                                     |
| 24.1    | Power of Attorney (included on the signature page).                                                                                                                                                                                                                            |
| 99.1    | Amended and Restated 2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q (File No. 36913) filed on August 13, 2021)                                                                                        |
| 99.2    | Form of Stock Option Grant Notice and Stock Option Agreement under 2014 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.15 to the Registrant's Registration Statement on Form S-1 (File No. 333-202660) filed on March 11, 2015)                         |
| 99.3    | Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2014 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.16 to the Registrant's Registration Statement on Form S-1 (File No. 333-202660) filed on March 11, 2015) |
| 99.4    | Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2014 Equity Incentive Plan (incorporated herein by reference to Exhibit 10.4 to the Registrant's Quarterly Report on Form 10-Q as filed with the SEC on May 14, 2019)                   |
| 107.1*  | Filing Fee Table                                                                                                                                                                                                                                                               |

* Filed herewith

<div align='center'>4

SIGNATURES</div>

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on FormS-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Celebration, State of Florida, on th is 12thday of March, 2025.

| Zevra Therapeutics, Inc. |                                       |
| By:                      | /s/ R. LaDuane Clifton                |
|